We’re thrilled to announce the debut of 3T Biosciences with $40M in Series A financing! Born out of a lab at @Stanford, 3T is developing transformative therapies for the treatment of solid tumors and other diseases.
https://t.co/AHmkjkwhci
@lightspeedvp@BioWestlake@parkerici
If you want the best search engine c.1998, do you back the "experienced" CTO of @IBM, or 2 #PhD founders out of @Stanford building a startup w/ the goofy name @Google? #innovation often comes from those who are not yet 'world-leading', but soon will be. "Experience" you can hire.
Join GenScript at TIDES Digital Week as Dr. Marvin Gee, Co-Founder and Head of target Discovery at 3T Biosciences presents “High-throughput Identification of Intracellular Targets for Solid Tumors (June 4 at 10am EST)”. Register for the Event Here: https://t.co/iQRS7OhGZg!
PICI partner @3TBio (created out of PICI scientist Chris Garcia's lab @StanfordMed) aims to develop more effective T-cell receptor-based #celltherapies to defeat cancer by harnessing big data. They presented research at our #ScienceClub.